Glycomimetics inc (GLYC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenue

9,000

-

-

-

-

-

-

0

-

-

0

0

0

-

18

0

-

-

-

20,035

-

0

0

15,027

0

77

52

55

3,807

Costs and expenses:
Research and development expense

12,668

11,467

10,724

13,065

11,772

11,758

9,729

9,302

9,302

6,719

5,779

5,722

5,878

6,060

5,921

5,781

5,518

6,961

5,038

7,842

5,207

5,280

5,050

5,357

3,881

3,121

2,953

2,883

2,742

General and administrative expense

4,439

3,868

3,380

3,750

3,360

2,929

2,790

2,846

2,846

2,816

2,401

2,521

2,092

2,297

1,983

2,312

2,056

1,961

2,132

1,805

1,904

2,117

1,648

1,605

1,224

-

-

-

-

Total costs and expenses

17,108

15,335

14,105

16,815

15,133

14,687

12,519

12,148

12,148

9,535

8,181

8,243

7,970

8,358

7,905

8,093

7,575

8,922

7,171

9,648

7,112

7,398

6,699

6,962

5,106

3,944

3,753

3,552

3,348

Selling, general and administrative expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

800

668

605

Loss from operations

-8,108

-15,335

-14,105

-16,815

-15,133

-14,687

-12,519

-12,148

-12,148

-9,535

-8,181

-8,243

-7,970

-8,358

-7,886

-8,093

-7,575

-8,887

-7,171

10,386

-7,112

-7,398

-6,699

8,064

-5,106

-3,867

-3,700

-3,496

458

Interest income

445

608

853

986

1,049

1,052

944

363

870

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other income

-

-

-

-

-

-

-

870

-

-

231

102

39

-

32

21

20

5

3

2

3

4

4

4

4

-

0

-0

-

Loss and comprehensive loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,694

8,068

-

-

-3,700

-3,497

-

Income tax (benefit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-76

76

-

-

0

-

-

Total other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss and comprehensive loss

-7,662

-14,726

-13,251

-15,829

-14,083

-14,140

-11,575

-11,278

-11,278

-9,257

-7,950

-8,141

-7,931

-8,328

-7,854

-8,071

-7,554

-8,881

-7,168

10,389

-7,109

-7,393

-6,617

7,991

-5,101

-3,867

-3,700

-3,497

459

Basic and diluted net loss per common share (in dollars per share)

-0.18

-0.34

-0.31

-0.36

-0.33

-0.39

-0.27

-0.26

-0.26

-0.25

-0.24

-0.30

-0.34

-0.35

-0.34

-0.41

-0.40

-

-0.38

-

-0.37

-

-

-

-0.30

-

-3.00

-

-

Basic and diluted weighted-average number of common shares (in shares)

43,575

43,373

43,295

43,183

43,166

35,489

43,069

42,809

42,809

34,138

32,724

27,239

23,480

23,110

23,049

19,793

19,071

-

19,025

-

18,961

-

-

-

17,232

-

1,233

-

-

Earnings Per Share, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.55

-

-

-0.35

0.42

-

-

-

-3.70

0.49

Earnings Per Share, Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.51

-

-

-0.35

0.39

-

-

-

-3.70

0.04

Weighted Average Number of Shares Outstanding, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,011

-

-

18,893

18,807

-

-

-

946

930

Weighted Average Number of Shares Outstanding, Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,236

-

-

18,893

20,238

-

-

-

946

11,128